NRG Oncology phase II randomized trial of nivolumab with or without ipilimumab in patients with persistent or recurrent ovarian cancer Meeting Abstract


Authors: Burger, R.; Sill, M.; Zamarin, D.; Powell, D.; Frak, I.; Zivanovic, O.; Gunderson, C.; Ko, E.; Mathews, C.; Sharma, S.; Hagemann, A.; Khleif, S.; Aghajanian, C.
Abstract Title: NRG Oncology phase II randomized trial of nivolumab with or without ipilimumab in patients with persistent or recurrent ovarian cancer
Meeting Title: 17th Biennial Meeting of the International Gynecologic Cancer Society (IGCS)
Journal Title: International Journal of Gynecological Cancer
Volume: 28
Issue: Suppl. 2
Meeting Dates: 2018 Sept 14-16
Meeting Location: Kyoto, Japan
ISSN: 1048-891X
Publisher: Lippincott Williams & Wilkins  
Date Published: 2018-09-01
Start Page: 19
Language: English
ACCESSION: WOS:000471152400015
PROVIDER: wos
PUBMED: 30212387
DOI: 10.1136/00009577-201809002-00001
Notes: Meeting Abstract: IGCS8-1481 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Dmitriy Zamarin
    201 Zamarin
  2. Oliver Zivanovic
    291 Zivanovic